Segall Bryant & Hamill, LLC Astrazeneca PLC Transaction History

Segall Bryant & Hamill, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$69.91 - $75.81 $16,428 - $17,815	235 Added 5.71%	4,347 $311,000
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $4,718 - $12,081	89 Added 2.21%	4,112 $226,000
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $17,778 - $21,342	-300 Reduced 6.94%	4,023 $265,000
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $240,877 - $290,159	4,323 New	4,323 $286,000
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $211,056 - $249,383	-3,907 Closed	0 $0

Q3 2021 Nov 03, 2021	BUY	$55.56 - $60.79 $1,889 - $2,066	34 Added 0.88%	3,907 $234,000
Q2 2021 Aug 12, 2021	SELL	$48.42 - $60.18 $1.12 Million - $1.39 Million	-23,180 Reduced 85.68%	3,873 $231,000
Q1 2021 May 13, 2021	BUY	$47.16 - $54.44 $1.28 Million - $1.47 Million	27,053 New	27,053 $1.35 Million

1,521

502M

5.59M

3.18M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.